ADA example [Bioanalytics]

posted by mittyri – Russia, 2019-03-18 22:20 (1036 d 05:00 ago) – Posting: # 20047
Views: 3,997

Hi Helmut,

Thank you so much for the detailed answer!

» » Even in analytical methodology (say QC samples): isn't possible to handle that values (as they are) for example for the mean evaluation for some level of QC sample?

» Not sure what you mean here.

Sorry for incomplete/incorrect question.
Say ADA, getting cut-off point (IV B FDA)
What would be a best tactics for cut-off point selection?
Say the data of healthy volunteers is {100, BLOQ, BLOQ}


Edit: Guidance linked. [Helmut]

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,829 posts in 4,566 threads, 1,555 registered users;
online 7 (0 registered, 7 guests [including 5 identified bots]).
Forum time: Tuesday 03:20 CET (Europe/Vienna)

The generation of random numbers is too important
to be left to chance.    Robert R. Coveyou

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5